(Sr.) Medical Launch Project Manager at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Experience in building partnerships with cross-functional teams and forming productive networks
Ability to build, implement, and maintain a 'launch excellence model/tool' and portfolio management platform
Strong networking skills at local and global levels to leverage organizational experiences, expertise, and resources
Knowledge of external benchmarks to optimize launch planning, implementation, and processes
Coaching and support skills for product launch leaders across product lifecycle stages
Capability to monitor launch progress, identify risks, and coordinate risk management and solutions
Skills in influence, negotiation, and challenging teams to improve decision-making
Understanding of compliance policies, P2P and customer interactions, and launch readiness SOPs
Holistic and evidence-based mindset for launch activities from clinical trial design to commercial launch

Responsibilities

Build partnerships with all launch functions and form a strong ‘launch excellence network’
Engage and unite all medical teams and align with affiliate launch team on ‘launch excellence’ objectives
Build, implement, and maintain an ‘accountability and monitoring’ portfolio management platform to ensure deliverables are met
Monitor launch milestone progress, take action/escalation to remove barriers, report progress, and ensure visibility and support
Instil and facilitate a ‘holistic and evidence-based mindset’ to consider critical requirements throughout the launch process (from clinical trial design to commercial launch)
Build and draw on an extensive network with global stakeholders to support local progress (expertise, experiences, resources)
Support product launch teams when influence and negotiation is required
Challenge product launch teams to improve decision-making for optimal product launches
Use external benchmarks and learning to improve launch processes, planning, and implementation
Follow compliance policies surrounding P2P and customer interactions and all launch readiness related SOPs

Skills

Project Management

Launch Planning

Cross-Functional Collaboration

Risk Management

Stakeholder Networking

Process Optimization

Coaching

Benchmarking

Clinical Trial Design

Commercial Launch

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free